Flash glucose monitoring in patients with diabetes mellitus: simple, convenient, necessary

• Leonid Yu. Morgunov

Abstract

In the last decade, continuous glucose monitoring has become increasingly popular. The Freestyle Libre system is a Flash monitoring method that allows you to create a new paradigm for self-monitoring of glycemia. The use of the new technology with the help of flash monitoring of the FreeStyle libre system significantly improves glycemic control in patients with type 1 and 2 diabetes mellitus, reduces the frequency of hypoglycemic episodes and is economicaly more profitable than the traditional measurement of the level of glycemia using glucose meters. Using the cloud platform with the LibreView web interface, with the help of which doctors and patients can create a set of structured, understandable reports and share them, allows you to aggregate data on the glucose level of all patients attached to a medical institution, to carry out dynamic monitoring and control.

Keywords:diabetes mellitus, Flash monitoring, Freestyle Libre, continuous glucose monitoring, clinical case, LibreView Webinterface

REFERENCES

1. IDF Diabetes Atlas. 8^th ed. 2017. [Electronic resource]. URL: https://diabetesatlas.org/resources/2017-atlas.html (date of access July 31, 2019) (in Russian)

2. Standards of specialized diabetes care. Eds. by I.I. Dedov, M.V. Shestakova, A. Yu. Mayorov. 9^th ed. Moscow, 2019: 212 p. (in Russian)

3. Fokkert M.J., Damman A., van Dijk P.R., Edens M.A., Abbes S., Braakman J., et al. Use of FreeStyle Libre Flash Monitor Register in the Netherlands (FLARE-NL1): patient experiences, satisfaction, and cost analysis. Int J Endocrinol. 2019; 2019: 4649303. DOI: https://doi.org/10.1155/2019/4649303

4. Bianchi C., Aragona M., Rodia C., Baronti W., de Gennaro G., Ber-tolotto A., et al. FreeStyle Libre trend arrows for the management of adults with insulin-treated diabetes: a practical approach. J Diabetes Complications. 2019; 33 (1): 6-12. DOI: https://doi.org/10.1016/j.jdia-comp.2018.10.012

5. Yadegarfar G., Anderson S.G., Khawaja Z., Cortes G., Leivesley K., Metters A., et al. The FreeStyle Libre flash glucose monitoring system: how it has improved glycaemic control for people with type 1 diabetes in Eastern Cheshire, UK. Cardiovasc Endocrinol Metab. 2020; 9 (4): 171-6. DOI: https://doi.org/10.1097/XCE.0000000000000216

6. Varzic S.C., Steiner K., Centner M.G., Grgurevic M., Berkovic M.C., Majanovic S.K., et al. Assessment of FreeStyle Libre flash glucose monitoring system implementation in real life clinical setting: a prospective observational study. Diagnostics (Basel). 2021; 11 (2): 305. DOI: https://doi.org/10.3390/diagnostics11020305

7. Battelino T., Danne T., Bergenstal R.M., Amiel S.A., Beck R., Biester T., et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care. 2019; 42 (8): 1593-603. DOI: https://doi.org/10.2337/dci19-0028

8. Al Hayek A.A., Al Dawish M.A. Frequency of diabetic ketoacidosis in patients with type 1 diabetes using FreeStyle Libre: a retrospective chart review. Adv Ther. 2021; 38 (6): 3314-24. DOI: https://doi.org/10.1007/s12325-021-01765-z

9. Al Hayek A.A., Robert A.A., Al Dawish M.A. Acceptability of the FreeStyle Libre flash glucose monitoring system: the experience of young patients with type 1 diabetes. Clin Med Insights Endocrinol Diabetes. 2020; 13: 1179551420910122. DOI: https://doi.org/10.1177/1179551420910122

10. Al Hayek A.A., Al Dawish M.A. Assessing diabetes distress and sleep quality in young adults with type 1 diabetes using FreeStyle Libre: a prospective cohort study. Diabetes Ther. 2020; 11 (7): 1551-62. DOI: https://doi.org/10.1007/s13300-020-00849-3

11. Galindo R.J., Migdal A.L., Davis G.M., Urrutia M.A., Albury B., Zambrano C., et al. Comparison of the FreeStyle Libre pro flash continuous glucose monitoring (CGM) system and point-of-care capillary glucose testing in hospitalized patients with type 2 diabetes treated with basal-bolus insulin regimen. Diabetes Care. 2020; 43 (11): 2730-5. DOI: https://doi.org/10.2337/dc19-2073

12. Ogawa W., Hirota Y., Osonoi T., Tosaki T., Kato Y., Utsunomiya K., et al. Effect of the FreeStyle Libre™ flash glucose monitoring system on gly-cemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: an open label, prospective, multicenter trial in Japan. J Diabetes Investig. 2021; 12 (1): 82-90. DOI: https://doi.org/10.1111/jdi.13327

13. OyagQez I., Merino-Torres J.F., Brito M., Bellido V., Cardona-Her-nandez R., Gomez-Peralta F., et al. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus. BMJ Open Diabetes Res Care. 2020; 8 (1): e001330. DOI: https://doi.org/10.1136/bmjdrc-2020-001330

14. Hassanein M., Rashid F., Elsayed M., Basheir A., Al Saeed M., Abdel-gadir E., et al. Assessment of risk of fasting during Ramadan under optimal diabetes care, in high-risk patients with diabetes and coronary heart disease through the use of FreeStyle Libre flash continuous glucose monitor (FSL-CGMS). Diabetes Res Clin Pract. 2019; 150: 308-14. DOI: https://doi.org/10.1016/j.diabres.2019.01.038

15. Al Hayek A., Robert A.A., Al Dawish M. Impact of the FreeStyle Libre flash glucose monitoring system on diabetes-self-management practices and glycemic control among patients with type 2 diabetes in Saudi Arabia: a prospective study. Diabetes Metab Syndr. 2021; 15 (2): 557-63. DOI: https://doi.org/10.1016/j.dsx.2021.02.027

16. Miyatake T., Yamamoto S., Tamura M., Fujimori M., Takahashi Y., Sakuma I., et al. Use of flash glucose monitoring during the perioperative period of cardiac surgery in a patient with type 1 diabetes mellitus. Kyobu Geka. 2019; 72 (8): 599-603.

17. Heald A.H., Rea R., Horne L., Metters A., Steele T., Leivesley K., et al. Analysis of continuous glucose tracking data in people with type 1 diabetes (T1DM) after COVID-19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medication. Int J Clin Pract. 2021; Aug 10: e14714. DOI: https://doi.org/10.1111/ijcp.14714

18. Wright E.E. Jr, Kerr M.S.D., Reyes I.J., Nabutovsky Y., Miller E. Use of flash continuous glucose monitoring is associated with A1C reduction in people with type 2 diabetes treated with basal insulin or noninsulin therapy. Diabetes Spectr. 2021; 34 (2): 184-9. DOI: https://doi.org/10.2337/ds20-0069

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)